The SARS-CoV2 pandemic has brought the subject of immunology to the forefront of the public’s attention over the past two years. The development of vaccines that have successfully broken the link between SARS-CoV2 infection and severe COVID-19 disease, reducing the number of people hospitalized and in intensive care following infection, has been a major health advance; however, immunology has always, understandably, been the focus of the editorial team of the European Journal of Immunology (EJI), a journal published by Wiley-VCH.

In celebration of Wiley-VCH’s 100^th anniversary, the role of the Journal in connecting with the immunological community and beyond, communicating the latest advances in immunology, and highlighting important immunological milestones are discussed.

Connecting with the immunological community and beyond

EJI is an official journal of the European Federation of Immunological Societies (EFIS), which is comprised of 35 immunology Societies located in Europe, Eurasia, and the Middle East. In turn, EFIS is a member of the International Union of Immunological Societies (IUIS) ensuring global representation, which is reflected in the international nature of EJI, in terms of both authorship and readership [1]. The individual member Societies, as well as EFIS and IUIS, are highly active by way of meetings, training, public outreach and awards that recognize the achievements of their members, with many of these activities being reported in EJI to ensure maximum exposure within the immunological community and beyond.

Meetings can vary from those with a subject focus and a more limited number of attendees, e.g. [2], through to the European and International Congresses of Immunology, which cover the breadth of immunology and are attended by several thousand immunologists. There are also meetings with a geographical focus promoting collaborations, such as the Chinese-German Cooperation Group Tumor Immunology [3]. The Abstracts of some of these meetings are published in EJI, see e.g. [4, 5], as are reports of those sessions that are of high general interest, such as the ‘Men and Women in Immunology’ session of the European Congress of Immunology that tackled the issue of underrepresentation of women in more senior career positions [6].